2010 RESEARCH AWARDS
CIRCULATING BIOMARKERS THAT PREDICT RESPONSE TO AN IRREVERSIBLE PAN-HER KINASE INHIBITOR IN EGFR-AMPLIFIED GBM.
PI: Andrew S. Chi, MD, PhD, Divisions of Hematology/Oncology and Neuro-Oncology, Department of Neurology
Massachusetts General/ Hospital and Harvard Medical School
Award: $150,000 for one year
TUMOR-SPECIFIC RADIATION SENSITIZATION IN GLIOBLASTOMA BY TARGETING THE P53-INDEPENDENT CHECKPOINT RESPONSE.
PI: Prakash Chinnaiyan, MD, Assistant Member Department of Radiation Oncology and Experimental Therapeutics
H. Lee Moffitt Cancer Center and Research Institute
Award: $150,000 for one year
FEASIBILITY STUDY OF A PERSONALIZED AND ADAPTABLE CANCER VACCINE FOR PATIENTS WITH GLIOBLASTOMA.
PI: Duane A. Mitchell, M.D., Ph.D., Assistant Professor of Neurosurgery, Associate Director, Duke Brain Tumor Immunotherapy Program
The Preston Robert Tisch Brain Tumor Center at Duke
Award: $150,000 for one year
PERSONALIZED IMMUNOTHERAPY FOR GLIOBLASTOMA: GENETIC SIGNATURES THAT MAY PREDICT RESPONSIVENESS.
PI: Robert M. Prins, Ph.D., Assistant Professor of Neurosurgery, U.C. Los Angeles School of Medicine
U.C.L.A. School of Medicine
Award: $150,000 for one year
